CC-17369 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of complex pharmaceutical compounds, particularly those targeting specific biological pathways. Its application is significant in the creation of small molecule inhibitors that are designed to modulate enzyme activity or receptor function, which can be crucial in treating various diseases. Researchers employ CC-17369 in the early stages of drug discovery to explore its potential efficacy in preclinical models, focusing on optimizing its pharmacokinetic and pharmacodynamic properties. Additionally, it is used in high-throughput screening assays to identify promising lead compounds for further development. The compound's role in advancing therapeutic innovations underscores its importance in the ongoing quest for novel and effective treatments.